These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1323781)

  • 1. Hepatitis C virus-related acute and chronic hepatitis in hemodialysis patients.
    Pluvio M; Saggese A; Cirillo D; Castellino P; Pempinello R; Iannece MD; Guarnaccia D; Tassinaro P; Pluvio C; Cicchella T
    Nephron; 1992; 61(3):322-3. PubMed ID: 1323781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus antibody response in acute and chronic non-A, non-B hepatitis.
    Tagger A; Ribero ML; Grossi A; Chiaramonte S; Bortolotti F; Tremolada F
    Nephron; 1992; 61(3):258-9. PubMed ID: 1323766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and clinical expression of HCV infection in hemodialysis patients.
    Pauri P; Salvoni G; Vitolo W; Carletti P; Fanciulli E; Ricciatti AM; Della Bella S; Mioli VA
    Nephron; 1992; 61(3):313-4. PubMed ID: 1323778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus in hemodialysis patients.
    Dentico P; Volpe A; Buongiorno R; Carlone A; Carbone M; Manno M
    Nephron; 1992; 61(3):307-8. PubMed ID: 1323776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis C virus antibodies in hemodialysis patients in the area of Milan.
    Gubertini G; Scorza D; Beccari M; Buccianti G; Costantino A; Spotti D; Graziani G
    Nephron; 1992; 61(3):271-2. PubMed ID: 1323769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors.
    Brugnano R; Francisci D; Quintaliani G; Gaburri M; Nori G; Verdura C; Giombini L; Buoncristiani U
    Nephron; 1992; 61(3):263-5. PubMed ID: 1323768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV incidence in a dialysis center: preliminary reports.
    Ippolito E; Aterini S; Salvadori M; D'Elia G; Amato M
    Nephron; 1992; 61(3):375-6. PubMed ID: 1323797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus in dialysis units: a multicenter study.
    Da Porto A; Adami A; Susanna F; Calzavara P; Poli P; Castelletto MR; Amici GP; Teodori T; Okolicsanyi L
    Nephron; 1992; 61(3):309-10. PubMed ID: 1323777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroconversion to hepatitis C virus in dialysis patients: a retrospective and prospective study.
    Medin C; Allander T; Roll M; Jacobson SH; Grillner L
    Nephron; 1993; 65(1):40-5. PubMed ID: 7692314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C: reality of a renal unit.
    Bracchi O; Orazi E; Lupi GP; Bronzieri C; Cornalba L; Grassi C
    Nephron; 1992; 61(3):369-70. PubMed ID: 1323795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of hepatitis C in a population of hemodialysis patients.
    Mosconi G; Campieri C; Miniero R; Colì L; Orsi C; La Manna G; De Sanctis LB; Stefoni S; Sprovieri G; Bonomini V
    Nephron; 1992; 61(3):298-9. PubMed ID: 1323773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection among kidney transplant recipients.
    Ponz E; Campistol JM; Bruguera M; Barrera JM; Gil C; Pinto JB; Andreu J
    Kidney Int; 1991 Oct; 40(4):748-51. PubMed ID: 1720826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of transmission of hepatitis C by hemodialysis.
    Sungur C; Ozkuyumcu C; Ozen S; Yasavul U; Turgan C; Caglar S
    Nephron; 1993; 64(2):313. PubMed ID: 7686637
    [No Abstract]   [Full Text] [Related]  

  • 14. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late seroconversion of C virus markers in hemodialysis patients.
    Oliva JA; Maymo RM; Carrio J; Delgado O; Mallafre JM
    Kidney Int Suppl; 1993 Jun; 41():S153-6. PubMed ID: 7686592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C and hepatitis B virus infection in hemodialysis patients and staff: a two year follow-up.
    Jankovic N; Cala S; Nadinić B; Varlaj-Knobloch V; Pavlović D
    Int J Artif Organs; 1994 Mar; 17(3):137-40. PubMed ID: 7519583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-A, non-B hepatitis: clinical laboratory course in patients on hemodialysis and its correlation with the presence of anti-hepatitis C virus antibodies.
    La Russa A; Bufano G; Cauzzi L; Pecchini P
    Nephron; 1992; 61(3):273-5. PubMed ID: 1323770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibodies to hepatitis C virus in hemodialysis patients.
    Kallinowski B; Theilmann L; Gmelin K; Andrassy K; Deppermann D; Weinel B; Kommerell B
    Nephron; 1991; 59(2):236-8. PubMed ID: 1659672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus in chronic hemodialysis patients with non-A, non-B hepatitis.
    Yoshida CF; Takahashi C; Gaspar AM; Schatzmayr HG; Ruzany F
    Nephron; 1992; 60(2):150-3. PubMed ID: 1313155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay.
    Mondelli MU; Cristina G; Piazza V; Cerino A; Villa G; Salvadeo A
    Nephron; 1992; 61(3):350-1. PubMed ID: 1323788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.